Cite this article: Ngo PT, Parmar H, Topilow A (2016) Primary Renal MALT Lymphoma: A Conservative Approach to a Rare Disease. J Clin Nephrol Res 3(4): 1045.
CentralBringing Excellence in Open Access
Journal of Clinical Nephrology and Research
*Corresponding authorPhuong Ngo, Jersey Shore University Medical Center, 1945 State Route 33, Neptune, NJ, 00753, USA, Tel: 732-776-4420; Fax: 732-776-4798; Email:
Primary Renal MALT Lymphoma: A Conservative Approach to a Rare DiseasePhuong T. Ngo*, Harsh Parmar, and Arthur Topilow Department of Medicine, Jersey Shore University Medical Center, USA
Abstract
Primary renal MALT lymphoma, a rarity, is an important diagnostic consideration for renal masses. It is an indolent disease that presents with nonspecific symptoms and is grossly similar to renal cell carcinoma on imaging. Management of the reported cases has been variable. There are currently no standardized treatment guidelines. We present a case of an 80-year-old man who was found to have a primary renal MALT lymphoma who underwent a partial nephrectomy without subsequent immunotherapy, chemotherapy or radiation therapy. A number of previous case reports also took a more conservative approach with surgery only and our patient, like theirs, is currently doing well without recurrence of disease. We present this case, therefore, to suggest approaching these low grade lymphomas with surgery only, without subjecting patients to further systemic treatments.
Tomography; CHOP: Cyclophosphamide,Hydroxydoxorubicin, Oncovine and Prednisone; R-CHOP: Rituximab, Cyclophosphamide,Hydroxydoxorubicin,Oncovine and Prednisone
INTRODUCTIONLow grade B-cell lymphoma of mucosa-associated lymphoid
tissue (MALT), first described by Isaacson and Wright in 1983, is now recognized as a distinct subtype in the classification of Non-Hodgkin’s lymphoma [1]. They are further subdivided into those arising in the stomach and those arising in non-gastric areas, commonly the small intestine, salivary glands, head and neck, lung, thyroid, breast, gallbladder, cervix and ocular adnexa [2,3]. The kidneys are commonly involved in systemic disease but rarely are they a primary site of lymphoma. Primary renal MALT lymphoma was first described by Colovic in 1999 and since then, to the best of our knowledge, there have been 26 other reported cases. Treatment has varied amongst these cases, including partial and radical nephrectomy, chemotherapy, immunotherapy and radiation. We present a patient who was incidentally found to have a primary renal MALT lymphoma that then underwent a left partial nephrectomy without further systemic treatment and is clinically well two years post surgery. Therefore, in addition to being an important differential for renal masses, primary renal MALT lymphomas can perhaps be treated with surgery alone.
CASE PRESENTATIONAn 80-year-old male with recent resection of a malignant
carcinoid in the colon presented for a routine follow up with report of decreased appetite, nocturia, weight loss and changes in his bowel habits since his colon resection. He denied flank pain, dysuria, hematuria, incontinence and hesitancy. Physical exam showed abdominal scars from his colon resection and hernia repairs but was otherwise unremarkable without palpable masses. Laboratory data showed chronic microcytic anemia and worsening acute kidney injury with creatinine of 1.76mg/dL from a baseline of 0.9-1.0mg/dL 6 months prior. He had a non-contrast computed tomography (CT) of the abdomen and pelvis for follow up of his colonic resection and was found to have a 36 mm exophytic lesion in the lower pole of the left kidney with soft tissue attenuation suspicious for renal cell carcinoma (Figure 1).
He then underwent a laparoscopic left partial nephrectomy. The specimen was 3.5 x 2.5 x 2.5cm unencapsulated solid mass with a pale pink to grey-white smooth, rubbery cut surface. There was also a small secondary nodule that was loosely attached to the surface of the larger nodule. Histologic exam revealed a small cell, B-cell lymphoma with extensive plasmacytic differentiation, which was consistent with extranodal marginal zone lymphoma of mucosal associated lymphoid tissue (MALT lymphoma). Flow cytometry showed monoclonal B-cell population with a large cell component with light chain restriction expressing CD19, CD20, CD23 and CD11c (Figure 2). He then underwent a bone marrow biopsy that was negative for lymphoma, confirming the MALT lymphoma was isolated to the left kidney. He received no further systemic treatment and is doing well 2 years after surgical treatment.
CentralBringing Excellence in Open Access
Ngo et al. (2016)Email:
J Clin Nephrol Res 3(4): 1045 (2016) 2/4
DISCUSSION MALT lymphomas are a subtype of Non-Hodgkin’s lymphoma
that arise in a variety of epithelial tissues but very rarely do they arise in the kidneys primarily. These marginal zone lymphomas typically occur in the setting of chronic stimulation of the immune system by reactive B-cell lymphoid tissue. For example, lymphomas in the stomach are associated with Helicobacter pylori resulting in chronic gastritis, lymphomas in the salivary gland are associated with Sjogren’s syndrome, and those of the thymus are associated with chronic thyroiditis [3]. Renal MALT lymphomas are again an anomaly in this regard, having no specific predisposing inflammatory condition. Khalil et al., conducted a population-based study on the incidence of marginal zone lymphomas in the United States from 2001-2009 and showed the overall rate of lymphomas increased with age [4]. Extrapolating from that, renal MALT lymphomas are perhaps due in part to the overall chronic inflammation and immune senescence that come with aging [5]. However, though the majority of reported cases involved elderly patients, Kato, et al reported a case of primary renal lymphomas arising in a 30-year-old male who presented with frequent urination and right lower abdominal pain [6].
The symptoms of renal MALT lymphomas are also seemingly nonspecific. The first case reported by Colovic et al., involved a 50-year-old man being treated for resistant hypertension who was incidentally found to have a right renal mass on routine ultrasound, and since then, cases have ranged from asymptomatic patients to those with flank pain, weight loss and hematuria. Our patient had weight loss with decreased appetite and nocturia as well as changes in bowel habits since his colon resection. His symptoms may have been due to the lymphoma, but they also could have been the result of his colon resection. The diagnosis of renal MALT lymphomas, therefore, has relied on imaging. Once
Figure 1 An exophytic lesion measuring 36mm in the lower pole of the left kidney.
Figure 2 Lymphoplasmacytic appearance of the tumor cells.
Table 1: Summary of previously reported cases.
Author Patient Symptoms Treatment Outcome
Parveen et al [3] 69F right upper quadrant abdominal pain nephrectomy, local radiation N/A
Colovic et al [7] 50M hypertension follow up nephrectomy N/A
Mhawech et al [8] 76F right flank pain, anorexia, weight loss and hypertension radical nephrectomy N/A
Jindal et al [9] 45M fever and abdominal pain radical nephrectomy and chemotherapy multiple relapses in 13 yrs
Tuzel et al [10] 43M N/A radical nephrectomy no recurrence after 28 mos
Mortlock et al [11] 84F lower extremity edema, shortness of breath, weight loss chemotherapy, not specified N/A
Qiu et al [12] 83F back pain rituximab no recurrence after 8 mos
Qiu et al [12] 53M asymptomatic partial nephrectomy no recurrence after 10 mos
Garcia et al [13] 77F N/A N/A no recurrence at 36 mos
Garcia et al [13] 65M N/A antiobiotics for renal actinomycosis no recurrence at 14 mos
Garcia et al [13] 54M N/A chemotherapy no recurrence at 36 mos
Garcial et al [13] 75M N/A nephrectomy, chemotherapy no recurrence at 12 mos
Garcial et al [13] 66M N/A nephrectomy no recurrence at 53 mos
Garcia et al [13] 83M N/A chemotherapy no recurrence at 9 mos
Garcia et al [13] 65F N/A nephrectomy N/A
CentralBringing Excellence in Open Access
Ngo et al. (2016)Email:
J Clin Nephrol Res 3(4): 1045 (2016) 3/4
Garcia et al [13] 47M N/A chemotherapy no recurrence at 42 mos
Kato et al [6] 30M frequent urination, right lower abdominal pain radical nephrectomy no recurrence after 28 mos
Jeon et al [14] 88M right flank pain and right costovertebral tenderness partial nephrectomy no recurrence at follow up,
time unspecifiedCyriac et al [15] 52F flank pain, intermittent hematuria chemotherapy N/A
Charitaki et al [16] 66F weakness, edema, dyspnea on exertion and hypertension chemotherapy, immunotherapy no recurrence after 3 yrs
Contreras et al [17] 71M gross hematuria radical nephrectomy N/A
Chi et al [18] 72F asymptomatic without physical exam findings; routine renal US chlorambucil and prednisolone N/A
Dedekam et al [19] 77M one episode of gross hematuria radiation no recurrence after 3 yrs
Seyed et al [20] 74F gross hematuria and flank pain radical nephrectomy and chemotherapy N/A
Niwa et al [21] 86F incidental finding on renal US during admission for UTI radical nephrectoureterectomy no recurrence after 4 mos
Vedovo et al [22] 82F previously found renal mass radical nephrectomy, rituximab no recurrence after 10 mos
diagnosis has been established, the treatment plans for these renal MALT lymphoma patients have differed.
In cases of gastric MALT lymphomas, therapy is aimed at eradicating H. pylori. Those who fail this initial treatment are then treated with localized radiation. Non-gastric MALT lymphomas are also similarly treated with surgery and local radiation with or without chemotherapy and immunotherapy. For primary renal MALT lymphomas, however, standardized therapeutic strategies have not yet been established. Of the 26 reported cases of renal MALT lymphomas, 15 had nephrectomy, 9 received chemotherapy, 1 was treated with only radiation and 1 with only rituximab. While the majority of patients who received chemotherapy and radiation have not had recurrence of disease at follow up, those who only had nephrectomy also have not had recurrence, bringing to question what the treatment of renal MALT lymphomas should be (Table 1). From the cases reviewed, only one patient had multiple recurrences, and he was initially treated with both nephrectomy and chemotherapy, showing nephrectomy alone may not be enough and adjuvant chemotherapy does not guarantee definitive treatment. Furthermore, our follow up of two years may not be sufficient time to see recurrence, let alone the few months used in the reviewed cases. However, the majority of patients who were treated conservatively with surgery alone appear to have fared as well as those who received additional systemic treatment.
CONCLUSION Several cases of primary renal MALT lymphomas seem to
have been treated successfully with surgery alone. Our patient similarly is doing well two years status post nephrectomy without further treatment, suggesting that these low grade lymphomas might be treated without additional systemic therapy.
ACKNOWLEDGEMENTSThe authors would like to thank Dr Zheng for his contributions.
REFERENCES1. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated
lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer. 1983; 52: 1410-1416.
2. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press. 2008.
3. Parveen T, Navarro-Roman L, Medeiros LJ, Raffeld M, Jaffe ES. Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue arising in the kidney. Arch Pathol Lab Med. 1993; 117: 780-783.
4. Khalil MO, Morton LM, Devesa SS, Check DP, Curtis RE, Weisenburger DD, et al. Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site. Br J Haematol. 2014; 165: 67-77.
5. Boren E, Gershwin ME. Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun Rev. 2004; 3: 401-406.
6. Kato Y, Hasegawa M, Numasato S, Monma N, Fujioka T. Primary mucosa-associated lymphoid tissue-type lymphoma arising in the kidney. Int J Urol. 2008; 15: 90-92.
7. Colović M, Hadzi-Djokić J, Cemerikić V, Colović R, Janković G, Dacić M. Primary MALT lymphoma of the kidney. Hematol Cell Ther. 1999; 41: 229-232.
8. Mhawech P, Ahearn J, Medeiros LJ. Pathologic quiz case. A unilateral renal mass in an elderly woman. Arch Pathol Lab Med. 2000; 124: 919-920.
9. Jindal B, Sharma SC, Das A, Banerjee AK. Indolent behavior of low-grade B lymphoma of mucosa-associated lymphoid tissue arising in the kidney. Urol Int. 2001; 67: 91-93.
10. Tuzel E, Mungan MU, Yorukoglu K, Basakci A, Kirkali Z. Primary renal lymphoma of mucosa-associated lymphoid tissue. Urology. 2003; 61: 463.
11. Mortlock AM, Lim CS, Morgan H, Wong TW, Joshi A, Kuttikat A, et al. Renal MALToma: an unusual lymphoma in a patient with lupus. Lupus. 2006; 15: 613-615.
12. Qiu L, Unger PD, Dillon RW, Strauchen JA. Low-grade mucosa-associated lymphoid tissue lymphoma involving the kidney: report of 3 cases and review of the literature. Arch Pathol Lab Med. 2006; 130: 86-89.
16. Charitaki E, Liapis K, Moutzouris DA, Marinos L, Adamidis K, Margellos V, et al. Primary renal MALT lymphoma presenting with cryoglobulinaemia. Nephrol Dial Transplant. 2011; 26: 3819-3821.
17. Contreras-Iba-ez JA, Diaz-Gomez L, Muriel Cueto PJ. Renal clear cell carcinoma synchronous with Non-Hodgkin lymphoma of MALT type B phenotype. Actas Urol Esp. 2010; 34: 815-826.
18. Chi PJ, Pei SN, Huang TL, Huang SC, Ng HY, Lee CT. Renal MALT
lymphoma associated with Waldenström macroglobulinemia. J Formos Med Assoc. 2014; 113: 255-257.
19. Dedekam E, Graham J, Strenge K, Mosier AD. Primary renal lymphoma mimicking a subcapsular hematoma: a case report. J Radiol Case Rep. 2013; 7: 18-26.
20. Asgari SA, Aval HB, Asgari SA, Kheradmand K. A unique case of kidney’s collecting system MALT lymphoma. Can Urol Assoc J. 2014; 8: E172-175.
21. Niwa N, Tanaka N, Horinaga M, Hongo H, Ito Y, Watanabe T, et al. Mucosa-associated lymphoid tissue lymphoma arising from the kidney. Can Urol Assoc J. 2014; 8: 86-88.
22. Vedovo F, Pavan N, Liguori G, Siracusano S, Bussani R, Trombetta C. Primary renal MALToma: A rare differential diagnosis for a recurrent renal mass after primary ablative therapy. Can Urol Assoc J. 2014; 8: 442-444.
